Table 1.
Patient characteristics
| Normal, N = 11 | UC*, N = 20 | CD*, N = 22 | |
|---|---|---|---|
| Age, years | |||
| 18–40 | 2 [18%] | 9 [45%] | 10 [45%] |
| ≥ 40 | 9 [82%] | 11 [55%] | 12 [55%] |
| Sex | |||
| Male | 5 [45%] | 11 [55%] | 12 [55%] |
| Female | 6 [55%] | 9 [45 %] | 10 [45%] |
| Smoking status | |||
| Never smoked | 4 [36%] | 10 [52%] | 10 [45%] |
| Ex smoker | 4 [36%] | 7 [35%] | 7 [32%] |
| Current smoker | 3 [28%] | 3 [13%] | 5 [23%] |
| Location | |||
| Caecum | 9 [48%] | ||
| Right colon | 2 [18%] | 1 [4 %] | |
| Transverse colon | 3 [27%] | 2 [10%] | 1 [4 %] |
| Left colon | 2 [18%] | 5 [25%] | 2 [8 %] |
| Sigmoid/rectum | 4 [37%] | 13 [65%] | 4 [16%] |
| Colon, mixed | 5 [20%] | ||
| Therapy | |||
| 5-ASA | n/a | 3 [15%] | 0 |
| Corticosteroids | n/a | 2 [10%] | 0 |
| 5-ASA/corticosteroids | n/a | 0 [0%] | 6 [27 %] |
| Biologics | n/a | 0 [0%] | 7 [32 %] |
| Mix of biologics | n/a | 5 [23%] | |
| Corticosteroids/immunomodulators | 10 [50%] | 0 | |
| No treatment | 11 [100%] | 5 [25%] | 4 [18%] |
*All patients included in this study had active inflammatory disease with mucosal inflammation scored as moderate/severe.